Arbutus Biopharma Corp Deferred Compensation Share-based Arrangements, Liability, Current
Arbutus Biopharma Corp (ABUS) had Deferred Compensation Share-based Arrangements, Liability, Current of $948.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent · last filed 2016-11-03
- 2016-09-30: Deferred Compensation Share-based Arrangements, Liability, Current $948.00K.
- 2016-06-30: Deferred Compensation Share-based Arrangements, Liability, Current $1.31M.
- 2016-03-31: Deferred Compensation Share-based Arrangements, Liability, Current $1.75M.
- 2015-12-31: Deferred Compensation Share-based Arrangements, Liability, Current $0.00.
| Period end | Deferred Compensation Share-based Arrangements, Liability, Current |
|---|---|
| 2016-09-30 | $948.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.31M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.75M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |